Healthcare provider profile · identity verified

David P Woolever, MD

Internal Medicine · DAYTON, WA · NPI 1982609533

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	238	46
Atorvastatin Calcium	Atorvastatin Calcium	217	59
Levothyroxine Sodium	Levothyroxine Sodium	205	58
Lisinopril	Lisinopril	163	44
Omeprazole	Omeprazole	153	38
Amlodipine Besylate	Amlodipine Besylate	152	44
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	140	31
Furosemide	Furosemide	101	26
Metoprolol Succinate	Metoprolol Succinate	96	30
Tamsulosin Hcl	Tamsulosin Hcl	95	26
Losartan Potassium	Losartan Potassium	93	27
Tizanidine Hcl	Tizanidine Hcl	85	21
Albuterol Sulfate Hfa	Albuterol Sulfate	76	22
Eliquis	Apixaban	75	18
Mirtazapine	Mirtazapine	75	13
Buspirone Hcl	Buspirone Hcl	74	15
Metformin Hcl	Metformin Hcl	73	18
Hydrochlorothiazide	Hydrochlorothiazide	70	22
Pantoprazole Sodium	Pantoprazole Sodium	70	22
Sertraline Hcl	Sertraline Hcl	68	15
Metformin Hcl Er	Metformin Hcl	65	18
Sumatriptan Succinate	Sumatriptan Succinate	63	suppressed
Lorazepam	Lorazepam	61	16
Prednisone	Prednisone	61	23
Tramadol Hcl	Tramadol Hcl	58	17
Montelukast Sodium	Montelukast Sodium	52	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	suppressed
Trazodone Hcl	Trazodone Hcl	51	12
Metoprolol Tartrate	Metoprolol Tartrate	50	suppressed
Finasteride	Finasteride	48	14
Ondansetron Odt	Ondansetron	44	13
Potassium Chloride	Potassium Chloride	44	14
Clopidogrel	Clopidogrel Bisulfate	43	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	43	12
Simvastatin	Simvastatin	43	12
Bupropion Xl	Bupropion Hcl	42	suppressed
Duloxetine Hcl	Duloxetine Hcl	42	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	41	suppressed
Meloxicam	Meloxicam	41	15
Alprazolam	Alprazolam	39	suppressed
Pregabalin	Pregabalin	39	suppressed
Spironolactone	Spironolactone	38	suppressed
Allopurinol	Allopurinol	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	33	11
Zolpidem Tartrate	Zolpidem Tartrate	33	15
Atenolol	Atenolol	31	suppressed
Ozempic	Semaglutide	31	suppressed
Fluticasone Propionate	Fluticasone Propionate	29	suppressed
Oxycodone Hcl	Oxycodone Hcl	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Azithromycin	Azithromycin	27	19
Carvedilol	Carvedilol	27	suppressed
Ibuprofen	Ibuprofen	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Estradiol	Estradiol	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Entresto	Sacubitril/Valsartan	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	15
Clonidine Hcl	Clonidine Hcl	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Baclofen	Baclofen	23	suppressed
Doxepin Hcl	Doxepin Hcl	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Jardiance	Empagliflozin	21	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	20	suppressed
Gemfibrozil	Gemfibrozil	20	suppressed
Testosterone Cypionate	Testosterone Cypionate	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Fluconazole	Fluconazole	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	13
Methocarbamol	Methocarbamol	19	suppressed
Niva Thyroid	Thyroid,pork	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Glipizide	Glipizide	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Terbinafine Hcl	Terbinafine Hcl	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Famotidine	Famotidine	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Temazepam	Temazepam	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Topiramate	Topiramate	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	12	suppressed
Bydureon Bcise	Exenatide Microspheres	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Nystatin	Nystatin	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Risperidone	Risperidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error